Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KYMR | AMGN | VRTX | GILD | BMY |
| Company | Kymera Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 49.93 | 321.78 | 505.35 | 93.40 | 55.40 |
| High | 51.14 | 321.78 | 506.65 | 93.40 | 55.40 |
| Low | 48.47 | 321.78 | 485.29 | 93.40 | 55.40 |
| Last | 49.48 | 321.78 | 493.64 | 93.40 | 55.40 |
| Change | +1.79 | -0.01 | -6.24 | +1.71 | +0.12 |
| % Change | +3.75% | unch | -1.25% | +1.86% | +0.22% |
| Volume | 683,400 | 2,110 | 1,648,700 | 24,027 | 265,342 |
| 20-Day Average Volume | 368,085 | 1,700,911 | 1,105,035 | 5,100,151 | 8,456,457 |
| Previous Close | 47.69 | 321.79 | 499.88 | 91.69 | 55.28 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 47.17 | 319.73 | 480.19 | 88.24 | 53.51 |
| 20-Day Raw Stochastic | 81.10% | 60.14% | 70.10% | 100.00% | 74.50% |
| 20-Day Relative Strength | 56.68% | 50.65% | 57.61% | 76.25% | 61.29% |
| Weighted Alpha | +123.32 | +18.03 | +30.48 | +33.86 | +16.68 |
| Today's Opinion | 100% Buy | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 80% Buy | 24% Buy | 88% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 56% Buy | 40% Buy | 8% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.80% since 10/30/24 | +0.51% since 10/31/24 | +3.91% since 10/30/24 | +5.16% since 10/31/24 | -0.66% since 10/31/24 |
| Low | 42.62 on 10/31/24 | 313.02 on 11/05/24 | 463.14 on 11/01/24 | 88.19 on 11/01/24 | 54.20 on 11/01/24 |
| High | 51.14 on 11/06/24 | 325.39 on 11/06/24 | 506.65 on 11/06/24 | 93.40 on 11/07/24 | 56.80 on 11/06/24 |
| 1-Month | |||||
| %Chg | +14.91% since 10/04/24 | +1.36% since 10/07/24 | +8.42% since 10/04/24 | +10.62% since 10/07/24 | +3.67% since 10/07/24 |
| Low | 41.61 on 10/07/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 84.17 on 10/11/24 | 51.31 on 10/15/24 |
| High | 51.14 on 11/06/24 | 329.17 on 10/11/24 | 506.65 on 11/06/24 | 93.40 on 11/07/24 | 56.80 on 11/06/24 |
| 3-Month | |||||
| %Chg | +19.46% since 08/06/24 | +2.97% since 08/07/24 | +4.08% since 08/06/24 | +26.22% since 08/07/24 | +19.14% since 08/07/24 |
| Low | 39.06 on 08/08/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 72.43 on 08/12/24 | 46.22 on 08/08/24 |
| High | 53.27 on 09/26/24 | 339.17 on 09/23/24 | 506.65 on 11/06/24 | 93.40 on 11/07/24 | 56.80 on 11/06/24 |
| 6-Month | |||||
| %Chg | +29.19% since 05/06/24 | +7.15% since 05/07/24 | +22.64% since 05/06/24 | +42.68% since 05/07/24 | +25.79% since 05/07/24 |
| Low | 29.24 on 06/28/24 | 295.30 on 06/13/24 | 394.03 on 05/07/24 | 62.07 on 05/31/24 | 39.35 on 07/05/24 |
| High | 53.27 on 09/26/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 93.40 on 11/07/24 | 56.80 on 11/06/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,204,572 | 172,972,768 | 127,409,472 | 114,153,312 | 112,117,616 |
| Shares Outstanding, K | 64,765 | 537,533 | 258,102 | 1,244,992 | 2,028,177 |
| Annual Sales | 78,590,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -146,960,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 3,740,000 | 8,503,000,000 | 2,645,600,000 | 6,954,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -62,490,000 | 2,830,000,000 | -3,593,600,000 | 1,614,000,000 | 1,211,000,000 |
| 60-Month Beta | 2.21 | 0.60 | 0.39 | 0.17 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.82 on 10/31/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 10/31/24 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 09/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 0.00 | 19.20 | 47.82 |